ADNeT MCI to AD Predictor

This application predict the risk of progression from Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) for a new subject using demographic and biological features such as cognitive performance (e.g. MMSE score ≥27, indicating relatively preserved cognitive function despite MCI diagnosis), genetic risk factors (e.g. APOE4 positive status, which increases AD risk) and biomarker measurements (e.g. low Aβ value ≤44, suggesting lower levels of amyloid-beta protein)